Avrobio Inc (AVRO)
1.48
+0.04
(+2.78%)
USD |
NASDAQ |
May 31, 16:00
1.48
0.00 (0.00%)
After-Hours: 20:00
Avrobio Free Cash Flow: -50.48M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -50.48M |
| December 31, 2023 | -63.20M |
| September 30, 2023 | -78.84M |
| June 30, 2023 | -75.12M |
| March 31, 2023 | -89.72M |
| December 31, 2022 | -97.48M |
| September 30, 2022 | -100.55M |
| June 30, 2022 | -109.14M |
| March 31, 2022 | -101.08M |
| December 31, 2021 | -100.49M |
| September 30, 2021 | -104.31M |
| June 30, 2021 | -104.11M |
| March 31, 2021 | -104.42M |
| Date | Value |
|---|---|
| December 31, 2020 | -99.98M |
| September 30, 2020 | -88.76M |
| June 30, 2020 | -77.33M |
| March 31, 2020 | -74.19M |
| December 31, 2019 | -69.25M |
| September 30, 2019 | -61.83M |
| June 30, 2019 | -61.27M |
| March 31, 2019 | -51.32M |
| December 31, 2018 | -39.48M |
| September 30, 2018 | -36.46M |
| June 30, 2018 | -26.90M |
| March 31, 2018 | -20.94M |
| December 31, 2017 | -16.76M |
Free Cash Flow Range, Past 5 Years
-109.14M
Minimum
Jun 2022
-50.48M
Maximum
Mar 2024
-85.58M
Average
-89.24M
Median
Free Cash Flow Benchmarks
| AIM ImmunoTech Inc | -23.04M |
| Perspective Therapeutics Inc | -23.28M |
| Protalix BioTherapeutics Inc | 4.369M |
| Electromed Inc | 4.787M |
| Armata Pharmaceuticals Inc | -46.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.569M |
| Cash from Financing (Quarterly) | 0.03M |
| Free Cash Flow Per Share (Quarterly) | -0.169 |
| Free Cash Flow Yield | -76.39% |